Expectant management as an option for men with stage T1c prostate cancer: a preliminary study

被引:12
|
作者
Mohler, JL [1 ]
Williams, BT [1 ]
Freeman, JA [1 ]
机构
[1] Univ N Carolina, Div Urol, Dept Surg, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
D O I
10.1007/BF01300184
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The outcome of patients selecting observation of clinical stage Tie prostate cancer is unknown. A total of 101 men with clinical stage Tie prostate cancer were evaluated, counseled, and monitored in a standard fashion. Altogether, 27 men who elected observation were older and had greater co-morbidity but similar tumor characteristics as compared with 74 men who elected radical prostatectomy. In all, 9 men demonstrated clinical or biochemical evidence of progression after a mean follow-up of 23 months; 4 men who underwent radical prostatectomy had specimen-confined disease and undetectable post-operative levels of PSA. Observation appears to be a viable option for some men with clinical stage Tie prostate cancer.
引用
收藏
页码:364 / 368
页数:5
相关论文
共 50 条
  • [21] Expectant management of stage A-1 (T1a) prostate cancer utilizing serum PSA levels: A preliminary report
    Loughlin, KR
    Renshaw, AA
    Kumar, S
    JOURNAL OF SURGICAL ONCOLOGY, 1999, 70 (01) : 49 - 53
  • [22] Prostate specific antigen detected prostate cancer (clinical stage T1c): An interim analysis
    Lerner, SE
    Seay, TM
    Blute, ML
    Bergstralh, EJ
    Barrett, D
    Zincke, H
    JOURNAL OF UROLOGY, 1996, 155 (03): : 821 - 826
  • [23] Radiation therapy as treatment for stage T1c prostate cancers
    Gerald E. Hanks
    Alexandra L. Hanlon
    Wayne H. Pinover
    Tahseen I. Al-Saleem
    Timothy E. Schultheiss
    World Journal of Urology, 1997, 15 : 369 - 372
  • [24] Radiation therapy as treatment for stage T1c prostate cancers
    Hanks, GE
    Hanlon, AL
    Pinover, WH
    Al-Saleem, TI
    Schultheiss, TE
    WORLD JOURNAL OF UROLOGY, 1997, 15 (06) : 369 - 372
  • [25] DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme
    Isharwal, Sumit
    Makarov, Danil V.
    Carter, H. Ballentine
    Epstein, Jonathan I.
    Partin, Alan W.
    Landis, Patricia
    Marlow, Cameron
    Veltri, Robert W.
    BJU INTERNATIONAL, 2010, 105 (03) : 329 - 333
  • [26] Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy
    Mario C. Beduschi
    Ricardo Beduschi
    Joseph E. Oesterling
    World Journal of Urology, 1997, 15 : 346 - 358
  • [27] Factors that influence biochemical failure after radiation therapy for stage T1c prostate cancer
    Mohideen, MN
    McCall, AR
    Feinstein, J
    Sidrys, J
    Bricker, P
    Luka, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (01): : 6 - 11
  • [28] Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy
    Cookson, MS
    Fleshner, NE
    Soloway, SM
    Fair, WR
    UROLOGY, 1997, 49 (06) : 887 - 893
  • [29] Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer
    Pound, CR
    Walsh, PC
    Epstein, JI
    Chan, DW
    Partin, AW
    WORLD JOURNAL OF UROLOGY, 1997, 15 (06) : 373 - 377
  • [30] Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy
    Beduschi, MC
    Beduschi, R
    Oesterling, JE
    WORLD JOURNAL OF UROLOGY, 1997, 15 (06) : 346 - 358